|
||
J. Exp. Med.,
Volume 188, Number 6, September 21, 1998 1197-1202
By




From the * Department of Molecular Behavioral Biology, Osaka Bioscience Institute, Furuedai, Suita,
Osaka 565, Japan; Plasmodium falciparum causes the most severe form of human malaria, which kills ~1.5-2.7 million people every year, but the molecular mechanisms underlying the clinical symptoms and
the host-parasite interaction remain unclear. We show here that P. falciparum produces prostaglandins (PGs) D2, E2, and F2
PRESTO, Japan Science and Technology Corporation, Furuedai, Suita, Osaka
565, Japan; § R&D Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd. Shimo, Kita-ku,
Tokyo 115, Japan; and the
Department of Molecular Protozoology, Research Institute for Microbial
Diseases, Osaka University, Suita, Osaka 565, Japan
. After incubation with 1 mM arachidonic acid (AA), cell homogenates of P. falciparum produced PGs as determined by enzyme immunoassay and gas chromatography-selected ion monitoring. PG production in the parasite homogenate was not affected
by the nonsteroidal antiinflammatory drugs aspirin and indomethacin, and was partially heat resistant, whereas PG biosynthesis by mammalian cyclooxygenase was completely inhibited by
these chemicals and by heat treatment. Addition of AA to the parasite cell culture markedly increased an ability of the parasite cell homogenate to produce PGs and of parasitized red blood
cells to accumulate PGs in the culture medium. PGD2 and PGE2 accumulated in the culture
medium at the stages of trophozoites and schizonts more actively than at the ring stage. These
findings are the first evidence of the direct involvement of a malaria parasite in the generation
of substances that are pyrogenic and injurious to the host defenses. We will discuss a possible
contribution of the parasite-produced PGs to pathogenesis and host-parasite interaction of P.
falciparum.
;
pyrogen
This article has been cited by other articles:
| TABLE OF CONTENTS |
|